Decision Diagnostics Stock Price on September 7, 2023
| DECN Stock | USD 0.0001 0.00 0.00% |
Below is the normalized historical share price chart for Decision Diagnostics extending back to February 11, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Decision Diagnostics stands at 0.0001, as last reported on the 29th of November, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in Decision Stock, it is important to understand the factors that can impact its price. We have found three technical indicators for Decision Diagnostics, which you can use to evaluate the volatility of the firm.
At this time, Decision Diagnostics' Common Stock is very stable compared to the past year. As of the 29th of November 2024, Sale Purchase Of Stock is likely to grow to about 750.6 K, while Total Stockholder Equity is likely to drop about 413.5 K. . At this time, Decision Diagnostics' Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price To Book Ratio is likely to grow to 9.38, while Price To Sales Ratio is likely to drop 2.65. Decision Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta (1.78) |
Decision |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DECN |
Based on monthly moving average Decision Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Decision Diagnostics by adding Decision Diagnostics to a well-diversified portfolio.
Price Book 2.7161 | Enterprise Value 3.1 M | Enterprise Value Ebitda (1.49) | Price Sales 0.0168 | Shares Float 353.6 M |
Related Headline
Bone Biologics Headline on 7th of September 2023
Purchase by Deina Walsh of 300 shares of Bone Biologics by Deina Walsh
Filed transaction by Bone Biologics Corp officer. General open market or private purchase of non-derivative or derivative security
Decision Diagnostics Valuation on September 7, 2023
It is possible to determine the worth of Decision Diagnostics on a given historical date. On September 7, 2023 Decision was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Decision Diagnostics stock. Still, in general, we apply an absolute valuation method to find Decision Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Decision Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Decision Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 3,589 | |
09/07/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,667 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 600.00 |
| Backtest Decision Diagnostics | | | Decision Diagnostics History | | | Decision Diagnostics Valuation | Previous | Next |
Decision Diagnostics Trading Date Momentum on September 7, 2023
| On September 11 2023 Decision Diagnostics was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . The trading volume for the day was 600. The trading history from September 11, 2023 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Decision Diagnostics Fundamentals Correlations and Trends
By evaluating Decision Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Decision Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Decision financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Decision Diagnostics Stock history
Decision Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Decision is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Decision Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Decision Diagnostics stock prices may prove useful in developing a viable investing in Decision Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 409.9 M | 284 M | |
| Net Loss | -26.7 M | -25.4 M |
Decision Diagnostics Stock Technical Analysis
Decision Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Decision Diagnostics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Decision Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Decision Diagnostics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Decision Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Decision Diagnostics shares will generate the highest return on investment. By undertsting and applying Decision Diagnostics stock market strength indicators, traders can identify Decision Diagnostics entry and exit signals to maximize returns
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.